Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

What You Were Selling Last Week: British American Tobacco PLC (ADR) (BTI)

LONDON — One of Warren Buffett’s famous investing sayings is “Be fearful when others are greedy and greedy only when others are fearful”– in other words, sell when others are buying and buy when they’re selling.

But we might expect Foolish investors to know that, and looking at what Fools have been selling recently might well provide us with an indication of investments that may be past their prime.

So, in this series of articles, we’re going to look at what customers of The Motley Fool ShareDealing Service have been selling in the past week or so and what might have made them decide to do so.

Up in smoke
British American Tobacco PLC (ADR) (NYSEMKT:BTI)
has been a long-term FTSE 100 success story. Over the past decade, it’s delivered a 460% rise in share price, which equates to a market-thrashing 21% annualized return (the average is 9%).

British American Tobacco PLC (ADR) (NYSEAMEX:BTI)

The secret to its success, of course, has been selling a highly addictive product. Unfortunately, the product also causes cancer and all too often kills the customer. There is now an established trend of increasing resistance to tobacco products, both from consumers, who wish to give up for the sake of their health and their wallets, and from governments, which feel they have a duty to protect their citizens and have imposed ever-tighter restrictions on the advertising, sale, and consumption of cigarettes and related items.

As a result, tobacco companies are finding it ever more difficult to sell their products. In its latest annual report for the year to the end of 2012, British American Tobacco PLC (ADR) (NYSEMKT:BTI) revealed that overall cigarette volumes were down 1.6%, mainly due to “contractions” in some of the company’s larger markets. It’s that sort of thing that may have led some investors to decide that British American Tobacco PLC (ADR) (NYSEMKT:BTI)’s best days as an investment could well have gone up in smoke, and which put the company in the number 10 spot in the latest “Top Ten Sells” list*.

True, it’s not quite all doom-and-gloom. An interim management statement for first-quarter 2013, issued in April, announced that there had been some sales volume growth in some markets, such as Bangladesh, Pakistan, and Vietnam. But that was more than offset by much lower volumes in Brazil, and market declines in southern Europe, Eastern Europe, and the Middle East.

British American Tobacco PLC (ADR) (NYSEMKT:BTI) isn’t going to become a dreadful investment overnight, of course. And it’s developing a portfolio of “next-generation products,” including electronic nicotine delivery products — so-called e-cigarettes — which should help to at least partly offset what seems to be inevitable further decline in the conventional cigarette market.

But with its core revenues under increasing threat, some investors may be concluding that the only way for British American Tobacco PLC (ADR) (NYSEMKT:BTI) is down, and they will be looking for a better long-term home for their money.

The article What You Were Selling Last Week: British American Tobacco originally appeared on is written by Jon Wallis.

Jon Wallis and The Motley Fool have no position in any stocks mentioned.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!